Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CHST3 |
| Upstream (Parents) |
|---|
| (<<) ACTA2 → CHST3 |
| (<<) ACTN1 → CHST3 |
| (<<) ADAM12 → CHST3 |
| (<<) CEP170 → CHST3 |
| (<<) CTGF → CHST3 |
| (<<) CYR61 → CHST3 |
| (<<) EFEMP1 → CHST3 |
| (<<) ISLR → CHST3 |
| (<<) PRKCDBP → CHST3 |
| (<<) SULF1 → CHST3 |
| (<<) TIMP1 → CHST3 |
| (<<) VIM → CHST3 |
| Downstream (Children) |
|---|
| CHST3 → CYP1B1 (>>) |
| CHST3 → HIF1A (>>) |
| CHST3 → HSPA2 (>>) |
| CHST3 → IL6 (>>) |
| CHST3 → MAP3K6 (>>) |
| CHST3 → MMP14 (>>) |
| CHST3 → PCDH7 (>>) |
| CHST3 → PGF (>>) |
| CHST3 → SLC20A1 (>>) |
| CHST3 → UBE2D2 (>>) |
| CHST3 → WWTR1 (>>) |
